.With very early stage 1 data right now out in bush, metabolic disease outfit Metsera is actually lo...
.Rivus Pharmaceuticals has actually unveiled the data behind its own stage 2 weight problems succeed...
.Bristol Myers Squibb is paying Prime Medication $110 thousand ahead of time to cultivate reagents f...
.Novartis has inked a package likely worth much more than $1 billion with Flagship-founded Generate:...
.Recently debuted Metsera is unfolding some stage 1 data for its GLP-1 receptor agonist, disclosing ...
.In the middle of the genetic medicines branches ethnicity, Front runner Pioneering is actually reve...
.BioAge Labs is actually considering around $180 thousand in initial profits coming from an IPO as w...
.An attempt by Merck & Co. to open the microsatellite steady (MSS) metastatic intestines cancer c...
.Spain-based Asabys Allies has actually closed a fund of 180 thousand europeans ($ 200 thousand), lo...
.BioAge Labs is introducing practically $200 thousand using its Nasdaq IPO this morning, along with ...